Comparison of analytical and theoretical pharmaceutical concentrations in human urine in Germany.

Urine is considered as a valuable plant fertiliser due to its high nutrient content. However, urine also contains pharmaceuticals. Currently, little is known regarding expected pharmaceutical concentrations in urine and the resulting risks. Through series of analyses in Hamburg and Berlin and results from the development of a concentration prediction model this knowledge gap was intended to be filled. To which extent the theoretical calculations can substitute analyses of pharmaceuticals was also tested. Results showed that the model fits well for bezafibrate, carbamazepine, diclofenac, ibuprofen, phenazone, and pentoxifylline. In Hamburg an R(2) value of 0.98 and in Berlin of 0.90 was achieved for correlations between predicted and analysed concentrations. Additionally, it was shown that a sufficient number of people discharging their urine to the respective collection system are important to allow for reasonable predictions via calculation. Also, comparisons of predicted pharmaceutical concentrations to those determined in other projects showed good correlations. Overall, it can be concluded that in any case the calculated concentrations exceed the measured ones and are therefore conservative. This overestimation can be explained by several factors discussed in this article.

[1]  R. Ryhage,et al.  IDENTIFICATION AND QUANTIFICATION OF NEUTRAL FECAL STEROIDS BY GAS-LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY: STUDIES OF HUMAN EXCRETION DURING TWO DIETARY REGIMENS. , 1964, Journal of lipid research.

[2]  J. Clemens,et al.  A tool to evaluate the fertiliser value and the environmental impact of substrates from wastewater treatment. , 2007, Water science and technology : a journal of the International Association on Water Pollution Research.

[3]  B. Escher,et al.  Pilot experiments with electrodialysis and ozonation for the production of a fertiliser from urine. , 2007, Water science and technology : a journal of the International Association on Water Pollution Research.

[4]  Ralf Otterpohl,et al.  A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater. , 2008, The Science of the total environment.

[5]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[6]  H. Köhler,et al.  Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). , 2004, Aquatic toxicology.

[7]  S. Jørgensen,et al.  Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.

[8]  S. Webb.  A Data-based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals I — Collation of Available Ecotoxicity Data , 2004 .

[9]  J Lienert,et al.  Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine. , 2007, Water science and technology : a journal of the International Association on Water Pollution Research.

[10]  T. A. Larsen,et al.  Soft Paths in Wastewater Management – The Pros and Cons of Urine Source Separation , 2007 .

[11]  Keizo Sato,et al.  Environmental Risk Assessment for Pharmaceuticals , 2007 .

[12]  U. Schwabe,et al.  Arzneiverordnungs-Report 2004 , 2004 .

[13]  K. Kümmerer.  Pharmaceuticals in the Environment , 2001 .

[14]  Thomas Ternes,et al.  Pharmaceuticals and Metabolites as Contaminants of the Aquatic Environment , 2001 .

[15]  Christian G. Daughton,et al.  Pharmaceuticals and Personal Care Products in the Environment: Overarching Issues and Overview , 2001 .

[16]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.

[17]  T. Heberer.  Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.

[18]  R Otterpohl,et al.  Options for alternative types of sewerage and treatment systems directed to improvement of the overall performance. , 2002, Water science and technology : a journal of the International Association on Water Pollution Research.

[19]  S. Grundy,et al.  Metabolism of β-sitosterol in man , 1970 .

[20]  D. Aviado,et al.  Pharmacology of Pentoxifylline A Hemorheologic Agent for the Treatment of Intermittent Claudication , 1984, Angiology.

[21]  B. Escher,et al.  Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. , 2007, Environmental science & technology.

[22]  P. J. Jones,et al.  Dietary phytosterols: a review of metabolism, benefits and side effects. , 1995, Life sciences.

[23]  Eva Nilsson,et al.  Recovery of N and P from human urine by freezing, struvite precipitation and adsorption to zeolite and active carbon. , 2007, Bioresource technology.

[24]  Daniel Sutter,et al.  Screening test battery for pharmaceuticals in urine and wastewater , 2005, Environmental toxicology and chemistry.

[25]  Eva Nilsson,et al.  Plant availability of nutrients recovered as solids from human urine tested in climate chamber on Triticum aestivum L. , 2007, Bioresource technology.

[26]  B Vinnerås,et al.  The performance and potential of faecal separation and urine diversion to recycle plant nutrients in household wastewater. , 2002, Bioresource technology.

[27]  Willi Gujer,et al.  Urea hydrolysis and precipitation dynamics in a urine-collecting system. , 2003, Water research.